# PrimeLink BioTherapeutics

Source: https://onco.cc/companies/primelink-biotherapeutics/  
OnCo record `primelink-biotherapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

PrimeLink BioTherapeutics makes antibody-drug conjugates, including ones that carry two different cancer-killing drugs; its first, PLB-002, is in an early trial in advanced solid tumours.

## Summary

PrimeLink BioTherapeutics (普灵生物医药), based in Suzhou Industrial Park with a Shenzhen entity as the registry sponsor, develops antibody-drug conjugates on a modular conjugation platform it calls ENHANMIX, including dual-payload ADCs, degrader-antibody conjugates and bispecific ADCs. Its pipeline lists PLB-002, a monoclonal antibody ADC for ovarian and lung cancer, in a phase 1 study in advanced solid tumours (NCT07304128), with PLB-001, PLB-003, PLB-004 and PLB-005 earlier in development. Its first registered cancer trial, NCT07304128, was posted on ClinicalTrials.gov in December 2025.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- Also known as: Primelink BioTherapeutics (ShenZhen) Limited; 普灵生物医药（苏州）有限公司
- HQ: Suzhou
- Type: biotech
- Website: https://www.primelinkbio.com/

## Notes

- Company website (Chinese) and pipeline page read on 29 October 2026. The target of PLB-002 is not disclosed on the pages read. Founding year not stated. No financing amounts read.

## Sources

- Official website: https://www.primelinkbio.com/
- Pipeline: https://www.primelinkbio.com/pipeline/1.html
- ClinicalTrials.gov: phase 1 trial of PLB-002 (NCT07304128): https://clinicaltrials.gov/study/NCT07304128

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/), [Ovarian cancer](https://onco.cc/cancers/ovarian/)
- fronts: [Antibody-Drug Conjugates](https://onco.cc/fronts/adcs/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/), [Bispecific ADC](https://onco.cc/technologies/bispecific-adc/), [Dual-payload ADC](https://onco.cc/technologies/dual-payload-adc/)

---
JSON: https://onco.cc/api/v1/entities/primelink-biotherapeutics.json